Lessons learnt from pharmacovigilance audits and inspections
In drug development, maintaining high data quality is essential for regulatory success and patient safety. Discover key lessons and strategies helping sponsors and marketing authorization holders to navigate audits and inspections more confidently—from early development to post-approval activities.
Takeaways
- The focus of data auditors and inspectors
- The flaws and inconsistencies that raise concern
- The DO’s and DON’Ts of data presentation, learnt the hard way
Lunch is included, with limited spots available
